Dr Sarah Catchlove
Research Fellow, Clinical and Social Research Team, Turning Point and Monash University
Dr Sarah Catchlove PhD BSci(Hons) has a research background in psychopharmacology, cognitive neuroscience, psychophysiology and neuroimaging.
Before joining Turning Point in March 2023, Sarah was employed as an industry-funded post-doctoral researcher at the Centre for Human Psychopharmacology (CHP) at Swinburne University.
Prior to completion of a PhD in 2018, Sarah worked at CHP, St Vincent’s Private Hospital, Melbourne Sleep Disorders Centre and the School of Exercise and Nutrition Science at Deakin University in various roles including lecturer, sleep scientist, research assistant.
At Turning Point, Sarah is overseeing clinical trials investigating novel substances in the treatment of alcohol and drug addiction.
Collaborative studies include the behavioural and neurophysiological effects of cannabinoids in children with autism spectrum disorder; cannabidiol for exercise-induced muscle inflammation, and a large-scale project investigating gut microbiota, stress resilience and cognitive performance in Army recruits with the Australian Defence Science and Technology group. Recently completed projects include the effects of cannabis medication on driving performance, as well as observational studies investigating the efficacy of different types of cannabis medication.
Clinical trial design, regulatory affairs, drug discovery, and the potential health-enhancing mechanisms of novel pharmaceuticals, exercise and nootropic supplements, as well as direct effects on brain function.
You can contact Sarah at [email protected]